These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
411 related items for PubMed ID: 19037908
21. [Distribution of HIV resistance CCR5-delta 32, CCR2-64 I and SDF1-3'A alleles and their polymorphisms in the Han population in China]. Wang F, Jin L, Lei Z, Shi H, Hong W, Xu D, Shi M, Jiang J, Wang Y, Zhang B, Liu M, Li Y. Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Aug; 21(4):256-60. PubMed ID: 11860793 [Abstract] [Full Text] [Related]
26. Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study. Nahon P, Sutton A, Rufat P, Faisant C, Simon C, Barget N, Trinchet JC, Beaugrand M, Gattegno L, Charnaux N. Eur J Gastroenterol Hepatol; 2007 May 15; 19(5):425-31. PubMed ID: 17413295 [Abstract] [Full Text] [Related]
27. Determination of the CCR2-64I/CCR5-59653T haplotype linkage disequilibrium in a sample of Polish population. Lewandowska M, Trzeciak WH, Jagodzinski PP. Genetika; 2003 Jun 15; 39(6):831-3. PubMed ID: 12884524 [Abstract] [Full Text] [Related]
28. Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation. Abdi R, Huong TTB, Sahagun-Ruiz A, Murphy PM, Brenner BM, Milford EL, McDermott DH. J Am Soc Nephrol; 2002 Mar 15; 13(3):754-758. PubMed ID: 11856781 [Abstract] [Full Text] [Related]
29. Genetic polymorphisms of inflammatory molecules in Tunisian kidney transplantation. Krichen H, Khazen D, Sfar I, Ben Abdallah T, Bardi R, Jendoubi-Ayed S, Makhlouf M, Abderrahim E, Aouadi H, Ayed K, Gorgi Y. Transplant Proc; 2011 Mar 15; 43(2):433-6. PubMed ID: 21440726 [Abstract] [Full Text] [Related]
30. Effects of CCR5-delta32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis. Ioannidis JP, Contopoulos-Ioannidis DG, Rosenberg PS, Goedert JJ, De Rossi A, Espanol T, Frenkel L, Mayaux MJ, Newell ML, Pahwa SG, Rousseau C, Scarlatti G, Sei S, Sen L, O'Brien TR, HIV Host Genetics International Meta-Analysis Group. AIDS; 2003 Jul 25; 17(11):1631-8. PubMed ID: 12853745 [Abstract] [Full Text] [Related]
31. CCR2-64I is a risk factor for development of bladder cancer. Narter KF, Agachan B, Sozen S, Cincin ZB, Isbir T. Genet Mol Res; 2010 Apr 13; 9(2):685-92. PubMed ID: 20449800 [Abstract] [Full Text] [Related]
32. Genetic interactions between the donor and the recipient for susceptibility to acute rejection in kidney transplantation: polymorphisms of CCR5. Cha RH, Yang SH, Kim HS, Kim SM, Park MH, Ha J, Kim YS. Nephrol Dial Transplant; 2009 Sep 13; 24(9):2919-25. PubMed ID: 19561149 [Abstract] [Full Text] [Related]
33. Genotypes and polymorphisms of mutant CCR5-delta 32, CCR2-64I and SDF1-3' a HIV-1 resistance alleles in indigenous Han Chinese. Wang F, Jin L, Lei Z, Shi H, Hong W, Xu D, Jiang J, Wang Y, Zhang B, Liu M, Li Y. Chin Med J (Engl); 2001 Nov 13; 114(11):1162-6. PubMed ID: 11729511 [Abstract] [Full Text] [Related]
34. Genotypes of CCR2 and CCR5 chemokine receptors in human myasthenia gravis. Zhao X, Gharizadeh B, Hjelmström P, Pirskanen R, Nyrén P, Lefvert AK, Ghaderi M. Int J Mol Med; 2003 Nov 13; 12(5):749-53. PubMed ID: 14533004 [Abstract] [Full Text] [Related]
35. [Effect of CCR5delta32, CCR5m303, CCR2-64I and SDF1-3'A gene polymorphism on the prognosis of Chinese HIV-1 carriers]. Wang XH, Feng TJ, Wang FS, Chen L, Shi XD, Jin L. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep 13; 19(3):256-9. PubMed ID: 16261210 [Abstract] [Full Text] [Related]
36. Adverse effect of the CCR5 promoter -2459A allele on HIV-1 disease progression. Knudsen TB, Kristiansen TB, Katzenstein TL, Eugen-Olsen J, Copenhagen AIDS Study Group. J Med Virol; 2001 Nov 13; 65(3):441-4. PubMed ID: 11596075 [Abstract] [Full Text] [Related]
37. The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer. Kucukgergin C, Isman FK, Dasdemir S, Cakmakoglu B, Sanli O, Gokkusu C, Seckin S. Gene; 2012 Dec 10; 511(1):7-11. PubMed ID: 22982413 [Abstract] [Full Text] [Related]
38. Chemokine receptor gene polymorphisms and risk of human T lymphotropic virus type I infection in Jamaica. Hisada M, Lal RB, Masciotra S, Rudolph DL, Martin MP, Carrington M, Wilks RJ, Manns A. J Infect Dis; 2002 May 01; 185(9):1351-4. PubMed ID: 12001056 [Abstract] [Full Text] [Related]